Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology
Dr. Abbey presented the results from the Phase 1 DAVIO trial at ARVO 2023, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The trial was a first-in-human
read more
Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration
The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in
read more Dr. Abbey Featured in Retina Times
Texas Retina Associates’ Ashkan Abbey, MD, was featured in the “5 Questions” segment of the latest issue of Retina Today. In the article, he discusses his passion for retina research, what led
read more
Dr. Abbey Featured in New Retina Radio Podcast
Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in a recently released New Retina Radio podcast for retina surgeons titled “Tips for Mastering Secondary IOLs.” Dr. Abbey discussed approaches to implanting
read more Dr. Abbey Presented at the American Academy of Ophthalmology 2022 Meeting
Over the weekend, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a course titled “Secondary Intraocular Lens (IOL) Techniques for Retina Specialists” at the American Academy of Ophthalmology (AAO) 2022 meeting in Chicago,
read more Dr. Abbey Presented National Webinar on Treatment of Patients with Diabetic Macular Edema and 20/50 or Worse Vision
On Monday, September 19, 2022, Texas Retina Associates’ Ashkan M. Abbey, MD, delivered a webinar titled, “Does Treatment Selection Matter in Patients with Diabetic Macular Edema and 20/50 or Worse Vision?” Dr. Abbey discussed
read more
Dr. Abbey Presents at the American Society of Retina Specialists 2022 Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, is presenting this week at the 40th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) in New York City. ASRS is the
read more Dr. Abbey Presented Preliminary Findings of a Diabetic Macular Edema Clinical Trial at the Retina World Congress
Texas Retina Associates’ Ashkan M. Abbey, MD served as an invited faculty member for the Retina World Congress held May 12-15, 2022, in Fort Lauderdale, Florida. This global physician meeting featured presentations
read more
Dr. Abbey Spoke About Complications of a Compounded Medication Used in “Dropless” Cataract Surgery at the Vit-Buckle Society (VBS) Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, presented “Complications of Compounded Moxifloxacin-Triamcinolone” at the 10th Annual Meeting of the Vit-Buckle Society (VBS) held March 24 – 26, 2022, in Las Vegas. He
read more
Dr. Abbey Discusses COED Clinical Trial for Diabetic Macular Edema in New Video
In a new video published on Modern Retina, Texas Retina Associates’ Ashkan M. Abbey, MD, discusses the COED clinical trial which is testing the efficacy of combining steroid and anti-VEGF therapy in
read more